Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M55,295Revenue $M20,272Net Margin (%)15.1Z-Score2.7
Enterprise Value $M63,736EPS $3.6Operating Margin %19.5F-Score8
P/E(ttm))18.0Cash Flow Per Share $5.9Pre-tax Margin (%)18.0Higher ROA y-yY
Price/Book2.410-y EBITDA Growth Rate %14.6Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %4.8Current Ratio1.2Lower Leverage y-yY
Price/Cash Flow7.3y-y EBITDA Growth Rate %90.2ROA % (ttm)6.5Higher Current Ratio y-yY
Dividend Yield %2.1Insider Buy (3m)0ROE % (ttm)13.2Less Shares Outstanding y-yN
Payout Ratio %38.0Shares Outstanding M852ROI % (ttm)0.2Gross Margin Increase y-yY

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TEVATom Gayner 2014-12-31 Sold Out -0.67%$49.86 - $58.72
($55.72)
$ 64.9114%Sold Out0
TEVAGeorge Soros 2014-12-31 Reduce-0.55%$49.86 - $58.72
($55.77)
$ 64.9114%Reduce -22.01%4,859,966
TEVANWQ Managers 2014-12-31 Reduce-0.39%$49.86 - $58.72
($55.72)
$ 64.9114%Reduce -14.62%4,011,187
TEVAMichael Price 2014-12-31 Reduce-0.36%$49.86 - $58.72
($55.77)
$ 64.9114%Reduce -10.50%447,500
TEVADavid Dreman 2014-12-31 Reduce-0.16%$49.86 - $58.72
($55.77)
$ 64.9114%Reduce -23.89%119,838
TEVAJean-Marie Eveillard 2014-12-31 Add0.14%$49.86 - $58.72
($55.72)
$ 64.9114%Add 72.35%2,448,310
TEVAVanguard Health Care Fund 2014-12-31 Reduce-0.06%$49.86 - $58.72
($55.76)
$ 64.9114%Reduce -8.19%4,923,200
TEVAJames Barrow 2014-12-31 Add0.03%$49.86 - $58.72
($55.76)
$ 64.9114%Add 4.37%10,823,115
TEVAJohn Keeley 2014-12-31 Reduce-0.01%$49.86 - $58.72
($55.72)
$ 64.9114%Reduce -20.45%37,955
TEVARonald Muhlenkamp 2014-12-31 Reduce$49.86 - $58.72
($55.76)
$ 64.9114%Reduce -0.27%176,385
TEVACharles Brandes 2014-12-31 Buy $49.86 - $58.72
($55.72)
$ 64.9114%New holding3,600
TEVAGeorge Soros 2014-09-30 Reduce-0.42%$50.94 - $55.05
($52.93)
$ 64.9118%Reduce -14.32%6,231,722
TEVATom Gayner 2014-09-30 Reduce-0.36%$50.94 - $55.05
($52.93)
$ 64.9118%Reduce -36.02%444,000
TEVAVanguard Health Care Fund 2014-09-30 Reduce-0.27%$50.94 - $55.05
($52.93)
$ 64.9118%Reduce -26.99%5,362,100
TEVANWQ Managers 2014-09-30 Reduce-0.21%$50.94 - $55.05
($52.93)
$ 64.9118%Reduce -7.62%4,698,117
TEVAJean-Marie Eveillard 2014-09-30 Add0.19%$50.94 - $55.05
($52.93)
$ 64.9118%Add 710190.00%1,420,580
TEVAGeorge Soros 2014-06-30 Reduce-1.59%$48.69 - $54.06
($51.09)
$ 64.9121%Reduce -29.45%7,273,240
TEVAVanguard Health Care Fund 2014-06-30 Reduce-0.73%$48.69 - $54.06
($51.09)
$ 64.9121%Reduce -40.54%7,344,400
TEVANWQ Managers 2014-06-30 Reduce-0.56%$48.69 - $54.06
($51.09)
$ 64.9121%Reduce -19.21%5,085,717
TEVAJames Barrow 2014-06-30 Reduce-0.19%$48.69 - $54.06
($51.09)
$ 64.9121%Reduce -18.50%10,868,770
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TEVA is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about TEVA :

    Quarterly/Annual Reports about TEVA:

      News about TEVA:

      Articles On GuruFocus.com
      M&A’s Driving The Stock Indexes Ahead Apr 06 2015 
      Analysts Weigh in on Auspex Pharmaceuticals Following Teva Acquisition Mar 31 2015 
      Vanguard Health Care Fund Comments on Teva Pharmaceutical Industries Ltd Mar 27 2015 
      Vanguard Health Care Fund 2014 Annual Report Mar 27 2015 
      Impax Laboratories Inc. Steps Into Profitable Zone Feb 26 2015 
      Analysts are Bullish on IntelliPharmaceuticals Following Deal with Teva Pharmaceuticals Feb 04 2015 
      Weekly 52-Week Highs Highlight: ITW, ESRX, TEVA, CHD, STI Dec 08 2014 
      Zoetis in a Growing Global Animal Health Industry Dec 03 2014 
      Why Opko Health Is a Better Investment Than Apple Dec 02 2014 
      The Gurus’ Favorite Asian Stocks Sep 07 2014 

      More From Our Partners
      Stock Market News for April 06, 2015 - Market News Apr 6 2015 - ZACKS

      More From Other Websites
      Why Mylan, Teva and Perrigo are This Year's Valeant, Allergan and Actavis Apr 13 2015
      Teva to Present Multiple Sclerosis Data at 67th American Academy of Neurology (AAN) Annual Meeting... Apr 13 2015
      Teva to Present Multiple Sclerosis Data at 67th American Academy of Neurology (AAN) Annual Meeting... Apr 13 2015
      Can anything stop Teva Pharma? Apr 13 2015
      Israeli Stocks Head for Biggest Jump in 2 Years; Dubai Rises Apr 12 2015
      Natco Takes Patent Charge Honed in India to U.S. Market Apr 09 2015
      Mylan's Bid for Perrigo: A Time Line of Foreshadowing Apr 09 2015
      Barclays Is Boosting Teva's PT Apr 09 2015
      Should Mylan Marry Perrigo Or Teva? Street Debates Apr 09 2015
      Mylan Bid for Perrigo May Make Both Drugmakers Targets: Real M&A Apr 09 2015
      Everything is up for grabs in pharmaceuticals: Pro Apr 09 2015
      The Winner In A Mylan-Perrigo Deal? Teva, Says Citi Apr 09 2015
      Faber Report: Mylan to buy Perrigo Apr 09 2015
      And The Winner From The Mylan-Perrigo Merger Is... Teva? Apr 09 2015
      Mylan Offers $29 Billion For Perrigo, Sending Both Stocks Soaring To Highs Apr 08 2015
      Generic drugmaker Mylan offers $29 billion for Perrigo Apr 08 2015
      Generic drugmaker Mylan offers $29 billion for Perrigo Apr 08 2015
      Why This Analyst Just Downgraded Teva Apr 08 2015
      Generic Drug Stocks On Fire Apr 08 2015
      Teva Pharma downgraded by Standpoint Research Apr 08 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK